Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Authors
Keywords
-
Journal
PHARMACOLOGICAL RESEARCH
Volume 194, Issue -, Pages 106843
Publisher
Elsevier BV
Online
2023-07-04
DOI
10.1016/j.phrs.2023.106843
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses
- (2023) Paulina E. Stürzebecher et al. ATHEROSCLEROSIS
- Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
- (2023) Alberico L. Catapano et al. ATHEROSCLEROSIS
- Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
- (2023) Florian Kronenberg et al. ATHEROSCLEROSIS
- Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification
- (2023) Can Gollmann-Tepeköylü et al. CIRCULATION
- Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program
- (2023) Aeron M. Small et al. CIRCULATION
- Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein
- (2023) Peter E Thomas et al. EUROPEAN HEART JOURNAL
- Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion
- (2022) Amer Youssef et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target
- (2022) Marlys L. Koschinsky et al. ATHEROSCLEROSIS
- Recent advances in demystifying the metabolism of lipoprotein(a)
- (2022) Kévin Chemello et al. ATHEROSCLEROSIS
- Lipoprotein(a): An underestimated inflammatory mastermind
- (2022) Kim E. Dzobo et al. ATHEROSCLEROSIS
- Lipoprotein(a) and ethnicities
- (2022) Anurag Mehta et al. ATHEROSCLEROSIS
- Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene
- (2022) Stefan Coassin et al. ATHEROSCLEROSIS
- Existing and emerging strategies to lower Lipoprotein(a)
- (2022) Gregory G. Schwartz et al. ATHEROSCLEROSIS
- Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis
- (2022) Michael B. Boffa ATHEROSCLEROSIS
- Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology
- (2022) Marlys L. Koschinsky et al. ATHEROSCLEROSIS
- Mendelian Randomization: Principles and its usage in Lp(a) research
- (2022) Claudia Lamina ATHEROSCLEROSIS
- Non-genetic influences on lipoprotein(a) concentrations
- (2022) Byambaa Enkhmaa et al. ATHEROSCLEROSIS
- Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?
- (2022) Florian Kronenberg ATHEROSCLEROSIS
- Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective
- (2022) Benoit J. Arsenault et al. ATHEROSCLEROSIS
- Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
- (2022) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study
- (2022) Sofie Bay Simony et al. ATHEROSCLEROSIS
- Understanding the ins and outs of lipoprotein (a) metabolism
- (2022) Michael B. Boffa et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification
- (2022) Yannick Kaiser et al. EUROPEAN HEART JOURNAL
- Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
- (2022) Stephen J. Nicholls et al. NATURE MEDICINE
- Consensus and guidelines on lipoprotein(a) – seeing the forest through the trees
- (2022) Florian Kronenberg et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) and aortic valve stenosis: work in progress
- (2022) Florian Kronenberg EUROPEAN HEART JOURNAL
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
- (2022) Florian Kronenberg et al. EUROPEAN HEART JOURNAL
- Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
- (2022) Paul Lacaze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease
- (2022) Steven E Nissen et al. Open Heart
- Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood
- (2022) Olli Raitakari et al. CIRCULATION
- Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays
- (2022) Ioannis Dikaios et al. CLINICAL CHEMISTRY
- Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests
- (2022) L Renee Ruhaak et al. CLINICAL CHEMISTRY
- The effect of menopause on lipoprotein (a) concentrations: A systematic review and meta-analysis
- (2022) Panagiotis Anagnostis et al. MATURITAS
- Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. NEW ENGLAND JOURNAL OF MEDICINE
- The German Lipoprotein Apheresis Registry—Summary of the ninth annual report
- (2022) Volker J. J. Schettler et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Lipoprotein(a) and Aortic Valve Calcification
- (2022) Harpreet S. Bhatia et al. JACC-Cardiovascular Imaging
- Lipoprotein(a)-related cardiovascular and all-cause mortalities in Korean adults
- (2022) Byung Jin Kim et al. European Journal of Preventive Cardiology
- Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration
- (2021) M. Abdullah Said et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
- (2021) Johanna F. Schachtl-Riess et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
- (2021) Alexander Kille et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization
- (2021) Francesca Fasolo et al. CIRCULATION
- Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
- (2021) Yannick Kaiser et al. HEART
- Lipoprotein(a): Knowns, unknowns and uncertainties
- (2021) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis
- (2021) Lotte M de Boer et al. European Journal of Preventive Cardiology
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
- (2020) Johan G. Schnitzler et al. CIRCULATION RESEARCH
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Gene-based therapy in lipid management: the winding road from promise to practice
- (2020) Tycho R. Tromp et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
- (2020) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functions of the Plasminogen Receptor , Plg‐R KT
- (2020) Lindsey A. Miles et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)
- (2020) Gerald F. Watts et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease
- (2020) Rocío Salsoso et al. ADVANCES IN THERAPY
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
- (2020) Christa M Cobbaert et al. CLINICAL CHEMISTRY
- Lipoprotein(a) and Cardiovascular Disease
- (2020) Pia R Kamstrup CLINICAL CHEMISTRY
- Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)
- (2020) Santica M Marcovina et al. CLINICAL CHEMISTRY
- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
- (2019) Sotirios Tsimikas CIRCULATION RESEARCH
- Statin therapy increases lipoprotein(a) levels
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
- (2019) Kang H. Zheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
- (2019) Dick C. Chan et al. Journal of the American Heart Association
- Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes
- (2019) Claudia Lamina et al. JAMA Cardiology
- Potent reduction of plasma lipoprotein(a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis
- (2019) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
- (2019) Hubert Scharnagl et al. ATHEROSCLEROSIS
- The challenges of measuring Lp(a): A fight against Hydra?
- (2019) Florian Kronenberg et al. ATHEROSCLEROSIS
- Statins and increases in Lp(a): an inconvenient truth that needs attention
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
- (2019) Christian M. Madsen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
- (2019) A. Vuorio et al. JOURNAL OF INTERNAL MEDICINE
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes
- (2019) Daniel F. Gudbjartsson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in FinnsHighlights
- (2018) Gertraud Erhart et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
- (2018) Gerald F Watts et al. EUROPEAN HEART JOURNAL
- Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment
- (2018) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein(a) catabolism: a case of multiple receptors
- (2018) Sally P.A. McCormick et al. PATHOLOGY
- A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction
- (2017) Stefan Coassin et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium
- (2017) Christoph Waldeyer et al. EUROPEAN HEART JOURNAL
- Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial
- (2017) Tina Z. Khan et al. EUROPEAN HEART JOURNAL
- The metabolism of lipoprotein (a): an ever-evolving story
- (2017) Gissette Reyes-Soffer et al. JOURNAL OF LIPID RESEARCH
- A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
- (2017) Salome Mack et al. JOURNAL OF LIPID RESEARCH
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
- (2017) Rocco Romagnuolo et al. PLoS One
- Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular DiseaseHighlights
- (2016) Eberhard Roeseler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis
- (2016) Calvin Yeang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
- (2016) Gissette Reyes-Soffer et al. CIRCULATION
- Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)Novelty and Significance
- (2016) Monika Sharma et al. CIRCULATION RESEARCH
- SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)CLINICAL PERSPECTIVE
- (2016) Xiaoping Yang et al. Circulation-Cardiovascular Genetics
- Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease
- (2016) M. J. Nsaibia et al. JOURNAL OF INTERNAL MEDICINE
- PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor’s role
- (2016) Frederick J. Raal et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-density lipoprotein cholesterol on a roller coaster: where will the ride end?
- (2016) Florian Kronenberg KIDNEY INTERNATIONAL
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2016) Amirhosssein Sahebkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)CLINICAL PERSPECTIVE
- (2016) Xiaoping Yang et al. Circulation-Cardiovascular Genetics
- Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic ValveCLINICAL PERSPECTIVE
- (2015) Rihab Bouchareb et al. CIRCULATION
- Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
- (2015) Rocco Romagnuolo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
- (2015) Corey A. Scipione et al. JOURNAL OF LIPID RESEARCH
- Mendelian randomization: genetic anchors for causal inference in epidemiological studies
- (2014) G. Davey Smith et al. HUMAN MOLECULAR GENETICS
- Dramatic lowering of very high Lp(a) in response to niacin
- (2014) Min Li et al. Journal of Clinical Lipidology
- Lipoprotein(a) Levels in Familial Hypercholesterolemia
- (2014) Rodrigo Alonso et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
- (2014) Frederick J. Raal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population
- (2014) Elaine T. Lim et al. PLoS Genetics
- Causes and consequences of lipoprotein(a) abnormalities in kidney disease
- (2013) Florian Kronenberg Clinical and Experimental Nephrology
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
- (2013) Gregor Leibundgut et al. JOURNAL OF LIPID RESEARCH
- Scavenger receptor-BI is a receptor for lipoprotein(a)
- (2013) Xiao-Ping Yang et al. JOURNAL OF LIPID RESEARCH
- Elevated Expression of Lipoprotein-Associated Phospholipase A2 in Calcific Aortic Valve Disease
- (2013) Ablajan Mahmut et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Associations with Valvular Calcification and Aortic Stenosis
- (2013) George Thanassoulis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
- (2012) Pia R. Kamstrup et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions
- (2012) Rogier A. van Dijk et al. JOURNAL OF LIPID RESEARCH
- Nicotinic acid inhibits hepaticAPOAgene expression: studies in humans and in transgenic mice
- (2012) Indumathi Chennamsetty et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
- (2012) Anna Helgadottir et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) metabolism: Potential sites for therapeutic targets
- (2012) Jane Hoover-Plow et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)
- (2012) Taewoo Cho et al. MOLECULAR BIOLOGY OF THE CELL
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein-Derived Lysophosphatidic Acid Promotes Atherosclerosis by Releasing CXCL1 from the Endothelium
- (2011) Zhe Zhou et al. Cell Metabolism
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
- (2010) Tracie A. Seimon et al. Cell Metabolism
- Lipoprotein(a) accelerates atherosclerosis in uremic mice
- (2010) Tanja X. Pedersen et al. JOURNAL OF LIPID RESEARCH
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway
- (2008) Taewoo Cho et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
- (2008) Frederick F Samaha et al. Nature clinical practice. Cardiovascular medicine
- Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
- (2007) Andreas Gille et al. Annual Review of Pharmacology and Toxicology
- Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population
- (2007) Pia R. Kamstrup et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now